HealthEquity, Inc.

HQY

US42226A1079

HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.

Sector

Software

Calendar

2024-02-22 - Investor Day

More about the company

Income Statement Evolution

More financial data

Ratings for HealthEquity, Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

68.48USD

Average target price

86.83USD

Spread / Average Target

+26.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
HEALTHEQUITY, INC.	+12.88%	5 876 M $
MICROSOFT CORPORATION	+54.02%	2781 B $
SYNOPSYS INC.	+74.14%	81 506 M $
CADENCE DESIGN SYSTEMS, INC.	+67.74%	70 717 M $
DASSAULT SYSTÈMES SE	+32.56%	62 479 M $
ATLASSIAN CORPORATION	+53.51%	49 640 M $
PALANTIR TECHNOLOGIES INC.	+180.40%	38 667 M $
THE TRADE DESK, INC.	+60.68%	34 630 M $
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+46.76%	26 415 M $
ROBLOX CORPORATION	+42.60%	25 467 M $

Other Software

Real-time Estimate Cboe BZX Other stock markets 01:50:40 2023-12-11 pm EST			5-day change	1st Jan Change
70.02 ^USD	+2.25%		+0.75%	+12.88%

Dec. 07	Deutsche Bank Raises HealthEquity Price Target to $88 From $85, Maintains Buy Rating	MT
Dec. 06	Wells Fargo Adjusts HealthEquity's Price Target to $93 From $89, Maintains Overweight Rating	MT

Deutsche Bank Raises HealthEquity Price Target to $88 From $85, Maintains Buy Rating	Dec. 07	MT
Wells Fargo Adjusts HealthEquity's Price Target to $93 From $89, Maintains Overweight Rating	Dec. 06	MT
HealthEquity's Fiscal Q3 Non-GAAP Earnings, Revenue Rise	Dec. 05	MT
Transcript : HealthEquity, Inc., Q3 2024 Earnings Call, Dec 05, 2023	Dec. 05	CI
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 Revenue $249.2M, vs. Street Est of $243.6M	Dec. 05	MT
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 EPS $0.60, vs. Street Est of $0.50	Dec. 05	MT
HealthEquity Guides For FY 2024 EPS of $2.08-$2.16 on Revenue of $985-$995 Million, vs CIQ Analyst Consensus of $2.03/Share on Revenue of $989 Million	Dec. 05	MT
HealthEquity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	Dec. 05	CI
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2024 and 2025	Dec. 05	CI
North American Morning Briefing : China Outlook -2-	Dec. 05	DJ
Deutsche Bank Raises HealthEquity's Price Target to $85 From $72, Maintains Buy Rating	Oct. 26	MT
Healthequity Insider Sold Shares Worth $143,704, According to a Recent SEC Filing	Sep. 26	MT
Healthequity Insider Sold Shares Worth $365,923, According to a Recent SEC Filing	Sep. 26	MT
Healthequity Insider Sold Shares Worth $464,896, According to a Recent SEC Filing	Sep. 25	MT
North American Morning Briefing : Stock Futures -2-	Sep. 22	DJ
Baird Upgrades HealthEquity to Outperform From Neutral, Raises Price Target to $87 From $79	Sep. 21	MT
HealthEquity, Inc. entered into a definitive agreement to acquire BenefitWallet?s Health Savings Account portfolio from Conduent Business Services, LLC for $425 million.	Sep. 17	CI
Deutsche Bank Adjusts HealthEquity Price Target to $72 From $71, Maintains Buy Rating	Sep. 07	MT
RBC Lifts PT on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance, Keeps Outperform Rating	Sep. 06	MT
Baird Adjusts Price Target on HealthEquity to $79 From $77, Maintains Neutral Rating	Sep. 06	MT
Barrington Raises PT on HealthEquity to $85 From $80 After Fiscal Q2 Results Surpass Expectations, Maintains Outperform Rating	Sep. 06	MT
RBC Lifts Price Target on HealthEquity to $77 From $75 After Fiscal Q2 Beat, Fiscal 2024 Guidance Boost, Keeps Outperform Rating	Sep. 06	MT
Transcript : HealthEquity, Inc., Q2 2024 Earnings Call, Sep 05, 2023	Sep. 05	CI
HealthEquity Fiscal Q2 Adjusted Profit, Revenue Increase; Boosts Fiscal 2024 Outlook	Sep. 05	MT
HealthEquity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	Sep. 05	CI

HealthEquity, Inc.

Equities

HQY